坤泰胶囊联合谷维素对围绝经期妇女内分泌紊乱的改善作用

发布时间：2018-04-28 00:39

本文选题：坤泰胶囊 + 谷维素　；参考：《辽宁中医杂志》2017年02期

【摘要】：目的:研究坤泰胶囊联合谷维素对围绝经期妇女内分泌紊乱的改善作用。方法:选取2013年8月—2014年8月本院接诊的60例围绝经期患者作为本次研究对象,按随机数表法分为观察组和对照组,对照组给予谷维素治疗,观察组给予坤泰胶囊联合谷维素进行治疗,观察两组患者治疗后E2、FSH、LH水平,血脂总胆固醇和甘油三酯水平,高、低密度脂蛋白胆固醇水平,症状改善,临床疗效。结果:治疗后,观察组E2(69.25±8.51)pmol/L优于对照组(45.09±7.23)pmol/L;FSH、LH(29.12±5.69、30.03±9.01)U/L均小于对照组(45.10±7.02、42.83±10.05)U/L,差异具有统计学意义(P0.05);观察组血脂总胆固醇和甘油三酯(7.56±1.23、3.02±1.01)mmol/L均小于对照组(8.97±2.13、5.97±1.28)mmol/L,差异具有统计学意义(P0.05);观察组高、低密度脂蛋白胆固醇水平(2.37±0.52、1.80±0.57)g/L均优于对照组(2.06±0.51、2.15±0.46)g/L,差异具有统计学意义(P0.05);观察组烦热出汗、失眠、情绪烦躁、心神不宁改善时间(12.09±3.01、14.01±2.10、10.20±2.13、13.09±2.72)d均小于对照组(21.03±6.23、19.52±5.10、19.70±6.10、20.17±6.08)d,差异具有统计学意义(P0.05);观察组临床疗效95.00%(57/60)优于对照组68.33%(41/60)差异具有统计学意义(P0.05)。结论:坤泰胶囊联合谷维素治疗围绝经期妇女内分泌紊乱疗效显著,值得临床推广。
[Abstract]:Objective: to study the effect of Kuntai capsule combined with oryzanol on endocrine disorder in perimenopausal women. Methods: from August 2013 to August 2014, 60 patients with peri-menopausal period were selected as the study objects. The patients were divided into observation group and control group according to random number method, the control group was treated with oryzanol, and the control group was treated with oryzanol. The observation group was treated with Kuntai capsule combined with oryzanol. After treatment, the levels of E _ 2 FSH LH, total cholesterol and triglyceride, high and low density lipoprotein cholesterol, symptom improvement and clinical efficacy were observed. Results: after treatment, the levels of E2P 69.25 卤8.51)pmol/L in the observation group were significantly higher than those in the control group (45.09 卤7.23 mmol / L, 29.12 卤5.69 卤30.03 卤9.01)U/L, 45.10 卤7.02 卤42.83 卤10.05 渭 mol / L, respectively), and the total cholesterol and triglyceride levels in the observation group were lower than those in the control group (8.97 卤2.135.97 卤1.28 mmol / L, P 0.05). The low density lipoprotein cholesterol (LDL-C) level of 2.37 卤0.52 卤1.80 卤0.57)g/L was significantly higher than that of the control group (2.06 卤0.51g / L, 2.15 卤0.46g / L, P 0.05). The improvement time of Xinshuning was 12.09 卤3.01 卤2.101 卤10.20 卤2.13, 13.09 卤2.72 days, which was lower than that of the control group (21.03 卤6.23 卤19.52 卤5.1070 卤6.10 卤20.17 卤6.08 d), the difference was statistically significant (P 0.05), and the clinical efficacy of the observation group was 95.000.57% (P < 0.05), which was better than that of the control group (68.33 卤41 / 60). Conclusion: Kuntai capsule combined with oryzanol in the treatment of endocrine disorders in perimenopausal women is worth popularizing.
【作者单位】：海口市中医医院妇产科;
【分类号】：R711.75

【相似文献】